TOCLUMI Trademark

Trademark Overview

On Tuesday, September 14, 2021, a trademark application was filed for TOCLUMI with the United States Patent and Trademark Office. The USPTO has given the TOCLUMI trademark a serial number of 97026751. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, October 15, 2024. This trademark is owned by Evergreen Theragnostics, Inc.. The TOCLUMI trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic radiopharmaceutical agents; Diagnostic radiopharmaceutical preparations; Diagnostic Radiopharmaceuticals agents for use in the field of nuclear medicine; Radiopharmaceuticals agents for use in the field of nuclear medicine, intended for medical imaging; Injectable diagnostic radiopharmaceutical agents; Diagnostic radiopharmaceutical agents for use in PET imaging; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Radiopharmaceutical preparations, in particular gallium coordination complexes and gallium DOTATOC for detecting cancer; Cold kit being gallium coordination complexes and gallium DOTATOC for use in imaging of neuroendocrine tumors
toclumi

General Information

Serial Number97026751
Word MarkTOCLUMI
Filing DateTuesday, September 14, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2022

Trademark Statements

Goods and ServicesDiagnostic radiopharmaceutical agents; Diagnostic radiopharmaceutical preparations; Diagnostic Radiopharmaceuticals agents for use in the field of nuclear medicine; Radiopharmaceuticals agents for use in the field of nuclear medicine, intended for medical imaging; Injectable diagnostic radiopharmaceutical agents; Diagnostic radiopharmaceutical agents for use in PET imaging; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Radiopharmaceutical preparations, in particular gallium coordination complexes and gallium DOTATOC for detecting cancer; Cold kit being gallium coordination complexes and gallium DOTATOC for use in imaging of neuroendocrine tumors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEvergreen Theragnostics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSpringfield, NJ 07081
Party NameEvergreen Theragnostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSpringfield, NJ 07081

Trademark Events

Event DateEvent Description
Friday, September 17, 2021NEW APPLICATION ENTERED
Wednesday, October 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 20, 2022ASSIGNED TO EXAMINER
Wednesday, April 27, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 27, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, April 27, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 27, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, April 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2022NOTICE OF ALLOWANCE CANCELLED
Thursday, July 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 17, 2022NEW NOA TO ISSUE
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 10, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 10, 2023SOU EXTENSION 1 FILED
Wednesday, May 10, 2023SOU EXTENSION 1 GRANTED
Friday, May 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 16, 2023SOU EXTENSION 2 FILED
Thursday, November 16, 2023SOU EXTENSION 2 GRANTED
Saturday, November 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 16, 2024SOU EXTENSION 3 FILED
Tuesday, April 16, 2024SOU EXTENSION 3 GRANTED
Wednesday, April 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 15, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 15, 2024SOU EXTENSION 4 FILED
Tuesday, October 15, 2024SOU EXTENSION 4 GRANTED
Monday, April 14, 2025SOU TEAS EXTENSION RECEIVED
Friday, May 23, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 23, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 23, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 23, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 23, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

toclumi radiopharmaceutical agents diagnostic imaging gallium complexes dotatoc coordination nuclear preparations